Dermata Therapeutics News

8-K: Current report

Jun 8 05:17

8-K: Current report

Jun 5 21:06

8-K: Current report

May 25 04:07

8-K: Current report

May 18 04:15

8-K: Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

May 16 04:19

8-K: Current report

May 15 21:06

8-K: Current report

May 14 21:19

8-K: Current report

May 8 05:18

Dermata Therapeutics | DEFA14A: Others

Mar 27 04:36

Dermata Therapeutics | DEF 14A: Definitive information statements

Mar 27 04:32

Dermata Therapeutics | 8-K: Current report

Mar 22 04:08

Dermata Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Mar 5 00:36

Dermata Therapeutics | 8-K: Current report

Jan 12 13:00

Dermata Therapeutics | DEF 14A: Definitive information statements

Dec 9, 2023 06:29

Dermata Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Dec 8, 2023 05:05

Dermata Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Nov 30, 2023 06:16

Dermata Therapeutics | 8-K: Current report

Nov 18, 2023 05:06

Dermata Therapeutics | 8-K: Current report

Nov 16, 2023 07:16

Dermata Therapeutics | 8-K: Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results

Nov 10, 2023 05:08

Dermata Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Sep 15, 2023 04:32